We’re going to get a new MF/PV drug
Yes, it’s true! Federatinib is back…and in the hands of its original creator. Forget the Sanofi nightmare. The FDA has lifted its clinical hold and Impact Biomedicines (Drs John Hood, Catriona Jamieson & Co.) is using Sanofi’s Phase III dataset and moving full speed to get this Jakafi competitor in our hands. And a strange twist to the story. Independent panel determines there never was any reason to abort the trial. Sanofi closed up shop before taking a closer look.
Plus News from ASH…an overview of the MPN scene by the Dean of Hematologists… The latest MPN Hero… A Scottsdale type meeting in San Antonio … Exploring the way interferon really works…plus the new List of Hematologists…and more. Enjoy
Happy Holidays from all of us at MPNforum
*This is an ADVANCE copy of the issue that will be published Thursday. Please send any corrections, typos, comments to ourMPNforum@gmail.com. Thanks.